Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis
Marla C. Dubinsky, Remo Panaccione, James D. Lewis, et al.
Crohn s & Colitis 360 (2022) Vol. 4, Iss. 3
Open Access | Times Cited: 23

Showing 23 citing articles:

Ulcerative Colitis in Adults
Beatriz Gros, Gilaad G. Kaplan
JAMA (2023) Vol. 330, Iss. 10, pp. 951-951
Closed Access | Times Cited: 253
Alleviative effects of exopolysaccharides from Limosilactobacillus mucosae CCFM1273 against ulcerative colitis via modulation of gut microbiota and inhibition of Fas/Fasl and TLR4/NF-κB pathways
Huizhen Li, Haitao Li, Catherine Stanton, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129346-129346
Closed Access | Times Cited: 10
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis
Simon Travis, Alison Potts Bleakman, Marla C. Dubinsky, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 6, pp. 939-949
Open Access | Times Cited: 18
Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus
Ferdinando D’Amico, Fernando Magro, Britta Siegmund, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 6, pp. 1009-1017
Closed Access | Times Cited: 17
Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission
Marla C. Dubinsky, David B. Clemow, Theresa Hunter, et al.
Crohn s & Colitis 360 (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 21
Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial
Jesse Siffledeen, Sunny Singh, Scott M. Shulman, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 5, pp. 1636-1648
Open Access | Times Cited: 4
Comprehensive care of ulcerative colitis: new treatment strategies
Thanaboon Chaemsupaphan, Arteen Arzivian, Rupert W. Leong
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Quercus infectoria galls mitigates colitis in mice through alleviating mucosal barrier impairment and suppressing inflammatory factors
Yan Ding, Jiaojiao Bai, Sabahat Ablimit, et al.
Journal of Ethnopharmacology (2025) Vol. 343, pp. 119487-119487
Closed Access
Efficacy and safety of two-step acupuncture therapy for symptom relief in adults with mild to moderate ulcerative colitis: rationale and design of the TSA-UC randomised controlled trial
He Chen, Jiufei Fang, Sixing Liu, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e094301-e094301
Open Access
Bowel urgency in ulcerative colitis assessed from patients’ reports: Results of a telemonitoring programme
E. Carboni, F Stalla, Marco Mendolaro, et al.
Digestive and Liver Disease (2025)
Open Access
Mirikizumab for Ulcerative Colitis: A Game-Changer or Just Another Incremental Advance?
Bisher Sawaf, Shahem Abbarh, Dahham Alsoud
Digestive Diseases and Sciences (2025)
Closed Access
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies
Millie D. Long, Stefan Schreiber, Toshifumi Hibi∥, et al.
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 3
Food-Related Quality of Life Is Impaired in Latinx and Non-Latinx Patients With Inflammatory Bowel Disease
Chunsu Jiang, Gala Godoy Brewer, Andrés Rodríguez, et al.
Gastro Hep Advances (2024) Vol. 3, Iss. 6, pp. 773-782
Open Access | Times Cited: 2
Insights into disability and psycho-social care of patients with inflammatory bowel disease
Olga Maria Nardone, Giulio Calabrese, Alessia La Mantia, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Patient interpretations of patient-reported outcome measures to assess bowel urgency: qualitative interviews in ulcerative colitis
Vipul Jairath, Theresa Hunter Gibble, Richard Moses, et al.
Journal of Patient-Reported Outcomes (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Burden of Bowel Urgency in Patients with Ulcerative Colitis and Crohn’s Disease: A Real-World Global Study
Raja Atreya, Isabel Redondo, Petra Streit, et al.
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Patient perception of bowel urgency and remission in moderately to severely active Crohn’s disease or ulcerative colitis: a qualitative study
Theresa Hunter, Larissa Stassek, Gale Harding, et al.
Journal of Patient-Reported Outcomes (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Xihuang pill ameliorates colitis in mice by improving mucosal barrier injury and inhibiting inflammatory cell filtration through network regulation
Meng-Lei Hu, Qian-Zan Liao, Bo-Tong Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117098-117098
Open Access | Times Cited: 3
Questionnaire Survey for Inflammatory Bowel Disease Patients in Japan; A Web-Based Japan, Crohn’s Disease, Ulcerative Colitis, Patients Survey
Takayuki Matsumoto, Keita Imai, Yuki Goda, et al.
Crohn s & Colitis 360 (2023) Vol. 5, Iss. 4
Open Access | Times Cited: 3
A Practical Guide to the Use of Mirikizumab
Edward L. Barnes
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 3, pp. 400-403
Closed Access | Times Cited: 1
Recent clinical evidence on nutrition, novel pharmacotherapy, and vaccination in inflammatory bowel diseases
Theodora Claudia Gheonea, Mária Bogdán, Andreea-Daniela Meca, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Letter: Change in bowel urgency in active ulcerative colitis patients treated with Curcumin-QingDai (CurQD): A post-hoc analysis of a randomized placebo-controlled trial
Shomron Ben‐Horin, Nir Salomon, Henit Yanai, et al.
Journal of Crohn s and Colitis (2024)
Closed Access
Editorial: Rectal Urgency Among Patients with Ulcerative Colitis or Crohn’s Disease: Analyses from a Global Survey
Mackenzie Moon, Reezwana Chowdhury, Aline Charabaty
Crohn s & Colitis 360 (2023) Vol. 5, Iss. 4
Open Access
Page 1

Scroll to top